Lexicon Pharmaceuticals Statistics

Total Valuation

LXRX has a market cap or net worth of $298.13 million. The enterprise value is $209.56 million.

Market Cap	298.13M
Enterprise Value	209.56M

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, after market close.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

LXRX has 363.18 million shares outstanding. The number of shares has increased by 48.46% in one year.

Current Share Class	363.18M
Shares Outstanding	363.18M
Shares Change (YoY)	+48.46%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	27.52%
Float	183.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.18
Forward PS	14.94
PB Ratio	2.42
P/TBV Ratio	3.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.86.

Current Ratio	2.22
Quick Ratio	2.19
Debt / Equity	0.86
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.25

Financial Efficiency

Return on equity (ROE) is -86.09% and return on invested capital (ROIC) is -33.06%.

Return on Equity (ROE)	-86.09%
Return on Assets (ROA)	-28.88%
Return on Invested Capital (ROIC)	-33.06%
Return on Capital Employed (ROCE)	-88.33%
Revenue Per Employee	$303,039
Profits Per Employee	-$1.72M
Employee Count	103
Asset Turnover	0.09
Inventory Turnover	234.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.14% in the last 52 weeks. The beta is 1.01, so LXRX's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-51.14%
50-Day Moving Average	0.68
200-Day Moving Average	0.90
Relative Strength Index (RSI)	59.62
Average Volume (20 Days)	4,920,041

Short Selling Information

The latest short interest is 37.56 million, so 10.34% of the outstanding shares have been sold short.

Short Interest	37.56M
Short Previous Month	38.83M
Short % of Shares Out	10.34%
Short % of Float	20.45%
Short Ratio (days to cover)	9.39

Income Statement

In the last 12 months, LXRX had revenue of $31.21 million and -$177.30 million in losses. Loss per share was -$0.51.

Revenue	31.21M
Gross Profit	-52.76M
Operating Income	-165.16M
Pretax Income	n/a
Net Income	-177.30M
EBITDA	-164.60M
EBIT	-165.16M
Loss Per Share	-$0.51

Full Income Statement

Balance Sheet

The company has $194.84 million in cash and $106.26 million in debt, giving a net cash position of $88.58 million or $0.24 per share.

Cash & Cash Equivalents	194.84M
Total Debt	106.26M
Net Cash	88.58M
Net Cash Per Share	$0.24
Equity (Book Value)	123.03M
Book Value Per Share	0.34
Working Capital	135.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$167.43 million and capital expenditures -$1.03 million, giving a free cash flow of -$168.46 million.

Operating Cash Flow	-167.43M
Capital Expenditures	-1.03M
Free Cash Flow	-168.46M
FCF Per Share	-$0.46

Full Cash Flow Statement

Margins

Gross Margin	-169.04%
Operating Margin	-529.15%
Pretax Margin	-568.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.46%
Shareholder Yield	-48.46%
Earnings Yield	-59.47%
FCF Yield	-56.50%

Analyst Forecast

The average price target for LXRX is $3.67, which is 347.07% higher than the current price. The consensus rating is "Buy".

Price Target	$3.67
Price Target Difference	347.07%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	41.57%
EPS Growth Forecast (5Y)	-29.10%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 21, 2015. It was a reverse split with a ratio of 0.1428571:1.

Last Split Date	May 21, 2015
Split Type	Reverse
Split Ratio	0.1428571:1

Scores

LXRX has an Altman Z-Score of -8.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.94
Piotroski F-Score	4